6 курс / Кардиология / Некоронарогенные_болезни_сердца_Коваленко_В_Н_,_Несукай_Е_Г_

. . — .: , 1979. -184 .

., . . — .: -

, 1983.— 95 .

., B.C., ., . -

, , // , . — 1 98 4 . - 9 . - . 75 - 8 1 .

: , /

. . . - ., 1998. — 28 .

., .

) // , . - 1999. - 12 - . 19-23.

., .

II) // , . — 2000. — 1. — . 15-20.

., ., B.C. -

// , . — 2000. — 4. —

. 75-77.

. :

? // , . - 2000. - 6. - . 60-63.

., .

// , . — 2000 — 4. — . 53—56.

., ., . . -

// . — 1 9 9 7 . - 2 - . 1 0 - 1 5 .

. . .

./ . . . — .: « » « », 1993. -794 .

., ., ., . -

// . — 1998. —

6. - . 63-65.

., PC, . -

( , , ). — : , 1985. — 188 .

Abelmann W. Virus and the heart (review) // Circulation. — 1971. — Vol. 44,5. - P. 950-956.

Abraham WT, Bristow V.R. Specialized centers for heart failure management // Circulation. - 1997. - Vol. 96. - P. 2755-2757.

Abraham W, William T Mechanisms of disease: hormones and hemodynamics in heart failure // New Engl. J. Med. - 1999. - Vol. 341. - P. 577-585.

Adams J.E., Divila-RominV.G., BesseyP.Q.etal. Improved detection of cardiac contusion with cardiac troponin I//Amer. Heart J. — 1996. — Vol. 131. — P. 308.

Akamatsu H., Amano J., Sakamoto . etal. Primary chylopericardium// Ann. Thorac. Surg. - 1994. - Vol. 58. - P. 262.

Angelini A., Thiene G., Boffa G.M. et al. Endocardial biopsy in arrhythmogenic right ventricular cardiomyopathy // J. Amer. Coll. Cardiol. — 1993. — Vol. 21. — P. 259A.

Archard L.C., Bowles N.E., Cunningham L. etal. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value // Europ. Heart J.- 1991.-Vol. 12, Suppl. D. - P. 56-59.

Aretz H .T Myocarditis. The Dallas Criteria // Hum.Pathol. - 1987. - Vol. 18. - P. 619-624.

Aretz H.T., Billingham M.E., Edwards W.D. et al. Myocarditis: a histopathologic definition and classification //Amer. J. Cardiovasc. Pathol. — 1987. — Vol. 1. — P. 3-13.

Arsan S., Mercan S., Sarigl A. et al. Long-term experience with pericardiectomy: analysis of 105 consecutive patients //Thorac. Cardiovasc. Surg. — 1994.—Vol.42. — P. 340.

AuffermannW.,WichterT, BreithardtG. etal. Arrhythmogenic right ventricular disease: MR imaging versus angiography //Amer. J. Radiol. — 1993. — Vol. 161. — P. 549-555.

Aukrust P., Ueland T, Lien E. et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy // Amer. J. Cardiol. — 1999.-Vol. 83.-P. 376-382.

Auten G.M., Del Bene V. Endocarditis: current guidelines on prophylaxis, diagnosis and treatment//Consultant. — 1996. — 5. — P. 973-993.

Avierinos J. F., Mohty D. M., Sarano M. E. Determinants of mitral valve prolapse prognosis in a large population based sample//Europ. Heart J. — 2000. —Vol. 21, Abstr. Suppl. - P. 303.

Awan N.A., Mason D.T Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure // Amer. Heart J. - 1996. -Vol. 131. - P. 177-185.

Azizi M., ChatelierG., GuyeneT. etal. Additive effects of combined angiotensinconverting enzyme inhibition and angiotensin II antagonism on blood pressure and

renin release in sodium-depleted normotensives//Circulation. — 1995. — Vol. 92. — P. 825-834.

Ball A.M., Sole M.J. Oxidative stress and the pathogenesis of heart failure// Cardiol. Clin. - 1998. - Vol. 16. - P. 665-675.

Bardales R.H., Stanley M.W., Schaefer R.F. et al. Secondary pericardia] malignancies: a critical appraisal of the role of cytology, pericardial biopsy, and DNA ploidy analysis //Amer. J. Clin. Pathol. - 1996. - Vol. 106. - P. 29.

Bayer A. S. Revised diagnostic criteria for infective endocarditis // Cardiol. Clin. — 1996.-Vol. 14.-P. 345-350.

Blake L.M., Scheinman M.M., Higgins C.B. MR features of arrhythmogenic right ventricular dysplasia// Amer. J. Radiol. - 1994. - Vol. 162. - P. 809-812.

Bonow R.O., Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management // Ann. Intern. Med. — 1992. - Vol. 117, 6. - P. 502-510.

Booz G.W., Baker K.M. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy // Hypertension. — 1996. — Vol. 28. - P. 635-640.

Bostman L.A., Salo J.A., Bostman O.M. Stab wounds to the pericardium and heart: an analysis of 85 consecutive patients// Europ. J. Surg. — 1992. — Vol. 158. — P. 271.

Bouhour J.B., Helias J., deLajartre A.Y. et al. Detection of myocarditis during the first year after discovery of a dilated cardiomyopathy by endomyocardial biopsy and gallium-67 myocardial scintigraphy: prospective multicentre French study of 91 patients // Europ. Heart J. - 1988. - Vol. 9. - P. 520-528.

Brandt R.R., FilzmaierK., JanssensU. etal. Increases of cardiac troponin I compared to creatin kinase in acute pericarditis // J. Amer. Coll. Cardiol. — 2000. — Vol.35, issue 2, Suppl. A. - P. 226.

Braunwald E. Heart failure.—Harrison's Principles of Internal Medicine— 13lh edition. McGraw-Hill, NY, 1994. - P. 998-1008.

Braunwald E. Heart disease/W.B.Saunders. Philadelphia, 3nd edition, 1995. — 1124p.

Braunwald E. Cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities // New Engl. J. Med. — 1997. — Vol. 337. — P. 13601369.

BreithardtG., WichterT, Haverkamp W etal. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy? Long QT

syndrome or no structural heart disease //Amer. Heart J . — 1994.—Vol. 127, Suppl. — P. 1151-1158.

Brown J., MacKinnon D., King A. et al. Elevated arterial blood pressure in cardiac tamponade // New Engl. J. Med. - 1992. - Vol. 327. - P. 463.

Brown M., Griffin G.E. Immune responces in endocarditis//Heart. — 1998. — Vol. 79. - P. 1-2.

Cai J., Jones D.P. Superoxide in apoptosis//J. Biol. Chem. — 1998. — Vol. 273. — P 11401-11404.

Califf R.M. Beta-blocker therapy for heart failure // J. A. M. A. - 2000. - Vol. 283, 10.-P. 1335-1337.

Carrasco H.A., Vicuna A.V., Molina C. et al. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage // Int. J. Cardiol. — 1985. — Vol. 9. — P. 425-428.

Castells E., Ferran V, Octavio de Toledo M.C. et al. Cardiac myxomas: surgical treatment, long-term results and recurrence//J. Cardiovasc. Surg. — 1993. — Vol. 34. _ R 49.

CharronPh., TessonR, PoirierO.etal. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy//Europ. Heart J. — 1999. —Vol.20. — P. 15871591.

Chojnowska L., Ruzyllo W. Rodzinna kardiomiopatia przerostowa // Kardiol. Pol. - 2000. - Vol. 53, Suppl. III. - P. 88-95.

ChowL.H., BeiselK.W, McManusB.M. Enteroviral infection of mice with severe combined immunodeficiency: evidence for direct viral pathogenesis of myocardial injury // Lab. Invest. - 1992. - Vol. 66. - P. 24-31.

Cleveland J.L., Ihle J.N. Contenders in Fas/TNF cell signalling //Cell. - 1998. - Vol. 81.-P. 479-482.

Cohen G.M. Caspases: the executioners of apoptosis//Biochem. J. — 1998. — Vol. 326.-P. 1-16.

Collier RE., Goodman G.B. Cardiac tamponade caused by central venous catheter perforation of the heart: a preventable complication //J. Am. Coll. Surg. — 1995.-Vol. 181.-P. 459.

CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure//New Engl. J. Med. — 1987. - Vol. 316. - P. 1429-1435.

CookS.A., Poole-Wilson P.A. Cardiac myocyte apoptosis//Europ. Heart J. — 1999. - Vol. 20. - P. 1619-1629.

Cowburn P.J., Cleland J.Y.F., Coats A.J.S. et al. Risk stratification in chronic heart failure // Europ. Heart J. - 1998. - Vol. 19. - P. 696-710.

Cowie M, R., Mosterd A., Wbod A. et al. The epidemiology of heart failure // Europ. Heart J. - 1997. - Vol. 18. - P. 208-225.

Craighead J.E., Huber S.A., Martin W.B. Murine cytomegalovirus // Europ. Heart J.- 1991.-Vol. 12 (Suppl. D). - P. 69-72.

Crozier I., Ikram H., Awan N. et al. Losartan in heart failure: Hemodynamic effects and tolerability//Circulation. — 1995. - Vol. 95, 3. - P. 691-697.

Dabrowska-Kugacka A., Lubinski A., Baczynska A. etal. Influence of structural abnormalities on dispersion of cardiac repolarisation in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy// Kardiol. Pol. — 2000. — Vol. 53. — P. 482-486.

Daliento L., RizzoliC.,ThieneG. etal. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy // Amer. J. Cardiol. — 1990. - Vol. 60. - P. 741-745.

Daubert J.C., Descaves C, Foulgoc J.L. et al. Critical analysis of cineangiographic criteria for diagnosis of arrhythmogenic right ventricular dysplasia // Amer. Heart J. - 1988. - Vol. 115. - P. 448-459.

DecG.M., FusterV. Idiopathic dilated cardiomyopathy//New Engl. J. Med. — 1994. - Vol. 331. - P. 1564-1575.

Dembinska-Kiec A. Rola cytokin w patomechanizmie niewydolnosci serca // KardioLPol. - 2000. - Vol. 53, Suppl. III. - P. 70-75.

Dickstein K., Chang P., Willenheimer R. et al. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure // J. Amer. Coll. Cardiol. — 1995. — Vol. 26.-P. 438-445.

Dougherty A. H. Congestive heart failure with normal systolic function // Amer. J. Cardiol. - 1984. - Vol. 54. - P. 778-782.

DurackD.T., Bright D.K., Lukes A.S. Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis //Amer. J. Med. — 1994. —Vol.96. — P. 200209.

Dutka D.P., Elborn J.S., Delamere F. et al. Tumour necrosis factoralpha in severe congestive cardiac failure//Brit. Heart J. — 1993.—Vol. 70. — P. 141-143.

Eriksson H. Heart failure: agrowing public health problem//J. Intern. Med. — 1995. -Vol. 237. -P. 135-141.

Espinosa R., Carrasco H.A., Belandria F. et al. Life expectancy analysis in patients with hagas disease. Prognosis after one decade (1973-1983)//Int. J. Cardiol. — 1985.-Vol. 8.-P. 45-48.

Evan G., Littlewood X A matter of life and cell death // Science. — 1998. - Vol. 281.-P. 1317-1321.

Feeley K. Necropsy diagnosis of myocarditis: a retrospective study using CD45RO immunohistochemistry//J. Clin. Pathol. - 2000. - Vol. 53, 2. - P. 147-149.

Feneley M.P. HIV-related cardiovascular disease // Med. J. Aust. — 1996. — Vol. 164.-P. 482.

Ferrari R. Tumor necrosis factor in chronic heart failure: a double facet cytokine // Cardiovasc. Res. - 1998. - \fol. 37. - P. 554-559.

Ferrari R., Bachetti ., Agnoletti L. et al. Endothelial function and dysfunction in heart failure//Europ. Heart J.- 1998.-Vol. 19, Suppl. G. - P. 41-47.

Ferrari R. Origin of heart failure: cardiac or generalized myopathy? // Europ. Heart J. - 1999. - Vol. 20. - P. 1613-1614.

Feuerstein G., Bril A., Ruffolo R. Protective effects of carvedilol in the myocardium//Amer. J. Cardiol. - 1997. - Vol. 80. - P. 41-45.

Figueroa W., Alankar S., Pai N. et al. Subxiphoid pericardial window for pericardial effusion in end-stage renal disease // Amer. J. Kidney Dis. — 1996. — Vol. 27.-P. 664.

Filipiak K.J., Tarchalska-Krynska ., Opolski F. Metaloproteinazy i ich udzial w przebudowie miesnia sercowego // Kardiol. Pol. — 2000. — Vol. 53, Suppl. III. — P. 83-87.

Fowler N.O. Cardiac tamponade: a clinical or an echocardiographic diagnosis? (editorial)//Circulation. - 1993. - Vol. 87. - P. 1738.

Fowler N.O. Constrictive pericarditis: its history and current status // Clin. Cardiol.- 1995.-Vol. 18.-P. 341.

Friedrich S.P. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis // Circulation. - 1991. - Vol. 90, 6. - P. 2761-2771.

Friman G. Myocarditis. Epidemiology, etiology and clinical aspects // Europ. Heart J. - 1995. - Vol. 16. - P. 173-175.

FuldaG., Rodriguez A., Turney S.Z. etal. Blunt traumatic pericardial rupture: a ten-year experience, 1979 to 1989 // J. Cardiovasc. Surg. - 1990. - Vol. 31. - P. 525.

Gaasch W.H. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction // JAMA. - 1994. - Vol. 271, 16. - P. 12761280.

Gandhi S.K., Marts B.C., MistryB.M. etal. Selective management ofembolized intracardiac missiles//Ann. Thorac. Surg.- 1996. - Vol. 62. - P. 290.

Garcia M.J., Rodriguez L., Ares M. et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging // J. Amen Coll. Cardiol. — 1996.-Vol. 27.-P. 108.

Gavras I. Bradykinin-mediated effects of ACE inhibition //Kidney Int. — 1992. — Vol. 42.-P. 1020-1029.

Gottlieb S,S., Dickstein K., Fleck E. et al. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure // Circulation. - 1993. - \fol. 88. - P. 1602-1609.

Granville D.J., Carthy ., Hunt D.W.C. etal. Apoptosis: molecular aspects of cell death and disease// Lab.Invest. - 1998. - Vol. 78. - P. 893-913.

Graupner C, Vilacosta I., San Roman J.A. et al. Risk of embolization after institution of antibiotic therapy in endocarditis //Europ. Heart J. — 2000. —Vol. 21, Abstr. Suppl. — P. 304.

Graupner C, Vilacosta L, Fernandez C. et al. Echocardiographic prognostic indicators in infective endocarditis // Europ. Heart J. — 2000. — Vol. 21, Abstr. Suppl. - P. 692.

Green D.R., ReedJ.C. Mitochondria and apoptosis//Science. — 1998. —Vol. 281.-P. 1309-1312.

Grossman W. Diastolic dysfunction in congestive heart failure // New Engl. J. Med.- 1991.-Vol. 325, 22. - P. 1557-1564.

Gullestad L., Aass H., Fjeld J. et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure // Circulation. — 2001. — Vol. 103.-P. 220-225.

HajjarR.J., RoseG.A., Madsen J.C. etal. Extrapericardial cardiac tamponade after blunt chest trauma (pt I)//Amer. Heart J . — 1995. — Vol. 130. — P. 620.

HamrellB.B., Huber S.A., Leslie K.O. Reduced unloaded sarcomere shortening velocity and a shift to a slower myosin isoform in acute murine coxsackievirus myocarditis // Circulation Res. - 1994. - Vol. 75, 3. - P. 462—472.

Hancock E.W. On the elastic and rigid forms of constrictive pericarditis // Amer. Hear t J.- 1980.-Vol. 100.-P. 917.

Hancock E.W. Subacute effusive-constrictive pericarditis // Circulation. — I971. - Vol. 43. - P. 183.

Hayashida W. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: Modification by long-term enalapril treatment //J. Amer. Coll. Cardiol. - 1993. - Vol. 22, 5. - P. 1403-1410.

466

Hazelrigg S.R., Mack M.J., Landreneau R.J. etal. Thoracoscopicpericardiectomy for effusive pericardial disease//Ann. Thorac. Surg. — 1993. — Vol. 56. — P. 792. Heart disease/Ed. E. Braunwald.- W.B. Saunders Company, 1988. - P. 1410— 1469.

Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effect of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients // New Engl. J. Med. - 2000. - Vol. 342. - P. 145-153.

Hengstenberg C, Maisch B. Neue aspekte in derdiagnostik entzundlicherund dilatativer herzmuskelerkrankungen // Herz Kreisl. — 1992. — Vol. 24, 6. — P. 179-183.

Herrera-Ganza E.H., Stetson S.J., Cubillos-Garzon A. et al. Tumor necrosis factor-a. A mediator of disease progression in the failing human heart // Chest. — 1999- - Vol. 115. - P. 1170-1174.

Herskowitz A., Ahmed-Ansari A. Myocarditis // Curr. Opinion in Cardiology. — 1992. - Vol. 7, 3. - P. 469-475.

Hersum M., Maisch B. Humoral and cellular immune reactions to the myocardium in myocarditis // Herz. — 1992. — Vol. 17, 2. - P. 91-96.

Hilgenberg A.D., Logan D.L., Akins C.W. et al. Blunt injuries of the thoracic aorta//Ann. Thorac. Surg. - 1992.- Vol. 53. - P. 233.

Hjalmarson A., Goldstein S., Fagenberg B. et al. Effects of controlled-release metoprolol on total mortality, hospitalization and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) //JAMA. - 2000. - Vol. 283, 10. - P. 1295-1302.

Ho K.K.L.,.Anderson K.M., Kannel W.B. et al. Survival after the onset of congestive heart failure in Framingham Heart Study Subjects // Circulation. — 1993.-Vol. 88.-P. 107-115.

Ho K.K.L., Pinsky J.L., Kannel W.B. etal. The epidemiology of heart failure: The Framingham Study//J. Amer. Coll. Cardiol. - 1993. - Vol. 22 (Suppl. A). - P6A-13A.

Hofling K., Tracy S. Expression of an antigenic adenovirus epitope in agroup coxsackievirus //J. Virol. - 2000. - V. 74, 10. - P. 4570-4578.

Hornig ., Arakawa A., Huber S.A. Viral myocarditis: a tale of two diseases // Lab. Invest. - 1992. - Vol. . - P. 1-3.

Houghton J.L. Pericarditis and myocarditis: which is benign and which isn't? // Postgrad. Med. - 1992. - Vol. 91, 2. - P. 273-278, 281-282.

Houser S.R., Lakatta E.G. Function of the cardiac myocyte in the conundrum of end-stage, dilated human heart failure // Circulation. — 1999. — Vol. 99. — P. 600-604.

Hunter J.J., Chien K.R. Mechanisms of disease: signalling pathways for cardiac hypertrophy and failure // New Engl. J. Med. - 1999. - Vol. 341. — P. 1276-1283.

Hurrell D.G., Nishimura R.A., Higano S.T. et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis//Circulation. — 1996. — Vol. 93. — P. 2007.

Iaccarino G., Lefkowitz R.J., Koch W.J. Myocardial G protein-coupled receptor kinase: implications for heart failure therapy // Proc. Assoc. Am. Physicians. — 1999. - Vol. 111. - P. 399-405.

Ikram H. Identifying the patient with heart failure //J. Int. Med. Res. — 1995. — Vol. 23.-P. 139-153.

Ishyiama S., Hiroe M., Nishikawa T. et al. Inhibitory effects of vesnarione in the progression of myocardial damage in experimental autoimmune myocarditis in rats // Cardiovasc. Res. - 1999. - Vol. 43. - P. 389-397.

Jibiki ., Terai M. Expression of tumor necrosis factor-alpha protein in the myocardium in fatal myocarditis// Pediatr. Int. — 2000. — Vol. 42, 1. — P. 43-47.

Johnson J.A. Diastolic dysfunction in congestive heart failure // Clin. Pharm. — 1991.-Vol. 10.-P. 850-861.

Johnson M.R., Gheorgiade M. Growth hormone therapy in patients with congestive heart failure: need for further research // Amer. Heart J. — 1999. — Vol. 137.-P. 899-901.

Jonsson B. Measurement of health outcome and associated costs in cardiovascular disease //Europ. Heart J.- 1996. - Vol. 17,Suppl.A. - P. 2-7.

Kandolf R., KirschnerP, AmeisD.etal. Enteroviral heart disease: diagnosis by in situ hybridization/Schultheiss H.P. ed. New concepts in viral Heart disease. Springer-Verlag, 1988. - P. 337-348.

Kandolf R., Klingel K., Mertsching H. et al. Molecular studies on enteroviral heart disease: pattern ofacute and persistent infection//Europ. HeartJ. — 1991. — Vol.12 (Suppl. D). - P. 49-55.

Kang PM., Izumo S. Apoptosis and heart failure: a critical review of literature // Circ. Res. - 2000. - Vol. 86. - P. 1107-1113.

Kasper E.K., Agema W.R.P., Huchins G.V. et al. The cause of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients //J. Amer. Coll. Cardiol. - 1994. - Vol. 23. - P. 586-590.

Keith M., Geranmayegan A., Sole M. et al. Increased oxidative stress in patients with congestive heart failure// J. Amer. Coll. Cardiol. - 1998. - Vol. 31. — P. 13521356.

King M.K., Gay D.M. , Pan L. C. et al. Treatment with a growth hormone secretagogue in a model of developing heart failure // Circulati on. — 2001. — Vol. 103.- P. 308-313.

Kinoshita O., Fontaine G., Rosas F. et al. Timeand frequency domain analysis of the signal -averaged ECG in patients with arrhythmogenic right ventricular d ysplasia // Circulati on. - 1995. - Vol. 91. - P. 715-721.

Klein J., Stanek G., Bittner R. et al. Lyme borreliosis as a cause of myocarditis and heart muscle di sease // Europ. HeartJ .- 1991.-Vol. 12, Suppl . D. - P. 7375.

Klingel K., Hohenadl C, Canu et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage and inflammation // Proc. Natl. Acad. Sci. USA. — 1 9 9 2 . - V o l . 8 9 . -P . 3 1 4 -3 1 8 .

Knott-Craig C.J., Dalton R.P., Rossouw G.J., et al. Penetrating cardiac trauma: management strategy based on 129 surgical emergencies over 2 years//Ann. Thorac. Surg. - 1992. - Vol. 53. - P. 1006.

Kojda G., Harrison D. Interactions between NO and reactive oxygen species : pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure // Cardiovasc. Res. - 1999. - Vol. 43. - P. 562 -571.

Krown K., Page T.P., Nguyen C. et al. Tumour necrosis factor alpha-induced apoptosis in cardiac myocytes //J. Clin. Invest. - 1996. - Vol. 98. - P. 2854-2865.

Kubota X, McNamara D.M., Wang J.J. et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure // Circulation. — 1998. - Vol. 97. - P. 2499-2501.

LabibS., UdelsonJ.E., PandianN.G. Echocardi ography in low pressure cardiac tamponade//Amer . J . Cardiol . - 1989 . - Vol . 63. - P. 1156 .

Laham R.J., Cohen D.J., Kuntz R.E. et al. Pericardial effusion in patients with cancer: outcome with contemporary management strategies // Heart. — 1996. — Vol. 75. - P. 67.

Lang K., Borner A., Figulla H. Comparison ofbiochemical markers for the detection of minimal myocardial injury: superior sensitivity of cardiac troponin-T//J. Intern. Med . - 2000. - V 247 . - 1 . - P. 119 -123 .

Lechat P. Prevention of heart failure progression: current approaches // Eur. Heart J. — 1998. - Vol. 19, Suppl. B. - P. 12-18.

Leclercq J.F., Coumel P. Late potentials in arrhythmogenic right ventricular dysplasia//Europ. Heart J.- 1993.-Vol. 14, Suppl. H. - P. 67-93.

Leport C. Antibiotic prophylaxis for infective endocarditis // Clin. Microbiol Infect. - 1998. - Vol. 4. - P. 56-61.

Levin S., Maldonada I., Rehm C. et al. Cardiac tamponade without pericardial effusion after blunt chest trauma //Amer. Heart J . — 1996. —Vol. 131. — P. 198.

Levine M.J., Lorell B.H., DiverD.J. etal. Implicationsofechocardiographically assisted diagnosis of pericardial tamponade in contemporary medical patients: detection before hemodynamic embarrassment//J. Amer. Coll. Cardiol. — 1991. — Vol. 17.-P. 59.

Levy D., Larson M.G., Vasan R.S. et al. The progression from hypertension to congestive heart failure //J. A. M. A. - 1996. - Vol. 275. - P. 1557-1562.

Li Y, Peng ., Yang Y High prevalence of enteroviral genomic sequences in myocardium// Heart. — 2000. — V. 83, 6. - P. 696-701.

Lie J.T. Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease //Ann. Int. Med. — 1988. — Vol. 109. — P. 25-28.

Lieberman E.B., Hutchins G.M., Herskowitz A. et al. A clinicopathologic description of myocarditis//J. Amer. Coll. Cardiol. — 1991. — Vol. 18. — P. 16171626.

Lindner J. R., Case R.A., Dent J.M. etal. Diagnostic value of echocardiography in suspected endocarditis // Circulation. — 1996. — Vol. 93. — P. 730-736.

Lobo F.V., Heggtveit H.A., Butany J. et al. Right ventricular dysplasia: morphological findings in 13 cases//Can. J. Cardiol. — 1992. — Vol. 8. — P. 261268.

Lorell B.H. Left ventricular hypertrophy and diastolic dysfunction // Hosp. Pract. - 1992. - Vol. 27, 10. - P. 189-209.

LucherT.F, Barton M. Biology of the endothelium//Clin. Cardiol. — 1997. — Vol. 10 (Suppl II).- P. 3-10.

Maenza R.L., Seaberg D., D'Amico F. A meta-analysis ofblunt cardiac trauma: ending myocardial confusion//Amer. J. Emerg. Med. — 1996. — Vol. 14. — P. 237.

Mahapatra R.K., Ellis G.H. Myocarditis and hepatitis virus // Angiology. — 1985.-Vol. 36.-P. 116-118.

Maisch B. The European study of epidemiology and treatment of cardiac inflammatory disease//Europ. Heart J. - 1997.-Vol. 116.— P. 1248-1254.

Maisch ., Portig I., Ristic A.etal. Definition of inflammatory cardiomyopathy (myocarditis): on the way to Consensus. A status report//Herz. — 2000. —Vol. 25, issue 3.-P. 200-209.

Mallat Z., Tedgui A., Fontaliran F. et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia //New Engl. J. Med. - 1996. - Vol. 335. - P. 1224-1226.

Mann D.L. Mechanisms and models in heart failure: a combination approach // Circulation. - 1999. - Vol. 100. - P. 999-1008.

Manolio T.A., Baughman K.L., Rodeheffer R. et al. Prevalence and etiology of idiopathic dilated cardiomyopathy//Amer. J. Cardiol. — 1992. —Vol.69. — P. 14581466.

Marcolongo R., Russo R., LavederF. etal. Immunosuppressive therapy prevents recurrent pericarditis // J. Amer. Coll. Cardiol. - 1995. - Vol. 26. - P. 1276.

Marcus F.I., Fontaine G., GuiraudonG. etal. Right ventricular dysplasia: a report of 24 cases //Circulation. - 1982. - Vol. 65. - P. 384-399.

Marcus L.C., Steere A.C., Duray PH. et al. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis//Ann. Intern. Med. — 1985. —Vol. 103. — P. 374-376.

Mason J.W. Distinct forms of myocarditis// Circulation. — 1991. — Vol. 83. — P. 1110—1111.

Masui ., Finck S., Higgins C.B. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging //Radiology. — 1991. —Vol. 182. — P. 369.

Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal disease//Circ. Res. - 1998. - Vol. 83. - P. 1182-1191.

McCarthy R.E., Bochmer J.P., Hruban R.H. et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis // New Engl. J. Med. - 2000. - Vol. 342. - P. 690-694.

McKenna W.J., Thiene G., Nava A. et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology//Brit. Heart J. - 1994. - Vol. 71. - P. 215-218.

McManus B.M., Chow L.H., Radio S.J. et al. Progress and challenges in the pathological diagnosis of myocarditis// Eur. Heart J. — 1991. —Vol. 12, Suppl. D. — P. 18-21.

MeldrumD.R. Tumour necrosis factor in the heart// Amer. J. Physiol. — 1998. — Vol. 274.-P. 577-595.

Mendosa I., Camardo J., Moleiro F. et al. Sustained ventricular tachycardia in chronic chagasic myocarditis //Amer. J. Cardiol. — 1986. — Vol. 57. — P. 423-424.

Melchior ., Ringsdal V., Hildebrandt P. et al. Recurrent acute idiopathic pericarditis treated with intravenous methylprednisolone given as pulse therapy// Amer. Heart J.- 1991. — Vol. 123. — P. 1086.

Milei J., BortmanG., Fernandez-AlonsoG. etal. Immunohistochemicalstaining of lymphocytes for the reliable diagnosis of myocarditis in endomyocardial biopsies // Cardiology. - 1990. - Vol. 77, 2. — P. 77-85.

Millaire A., de Groote P., Decoulx L. et al. Treatment of recurrent pericarditis with colchicine//Europ. Heart J. - 1994. - Vol. 15. — P. 120.

Moores D.W.O., Allen . ., Faber L.P. et al. Subxiphoid pericardial drainage for pericardial tamponade//J. Thorac. Cardiovasc. Surg. — 1995. —Vol. 109. — P. 546.

Muller J., 'Vv&llukat G., Dandel M. et al. Immunoglobulin absorption in patients with idiopathic dilated cardiomyopathy//Circulation. — 2000. — Vol. 101. — P. 385-391.

Nabauer M., Kaab S. Potassium channels down-regulation in heart failure // Cardiovasc. Res. - 1998. - Vol. 37. - P. 324-334.

Nagaratnam N., deSilva D.P.K.M., Gunawardene K.R.W. Myocardial involvement in infectious hepatitis//Postgrad. Med. J. — 1971. —Vol.47. — P. 785788.

Narang R., Swedberg K., Cleland J.G. F What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effects of ACE inhibitors on exercise capacity//Europ. Heart J. — 1996. — Vol. 17. — P. 120-134.

Narula J., Haider N., Virmani R. et al. Apoptosis in myocytes in end-stage heart failure // New Engl. J. Med. - 1996. - Vol. 335. - P. 1182-1189.

Nava A., Thiene G., Canciani B. et al. Familial occurrence of right ventricular dysplasia: a study involving nine families // J. Amer. Coll. Cardiol. — 1988. — Vol. 12.-P. 1222-1228.

NelsonG.S., BergerR.D., FebicsB.J. etal. Left ventricular orbiventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block//Circulation. — 2000. — Vol. 102. — P. 3053-3059.

Nieminen M.A., Heikkila J., Karjalainen J. Echocardiography in acute infectious myocarditis: Relation to clinical and electrocardiographic findings // Amer. J. Cardiol. - 1984. - Vol. 53. - P. 1331-1334.

Niggli E. Ca 2+ sparks in cardiac muscle: is there life without them? // News Physiol. - 1999. - Vol. 14. - P. 129-134.

Nimura H., Bachinski L., Songwatanaroj S. et al. Mutations in the gene for cardiac myosin-binding protein-C and late-onset familial hypertrophic cardiomyopathy// New Engl. J. Med. - 1998. - Vol. 338. - P. 1248-1257.

Nishiyama Y, Ikeda H., Haramaki N. et al. Oxidative stress is related to exercise intolerance in patients with heart failure // Amer. Heart J. — 1998. — Vol. 135. — P. 115-120.

NugueO., Millaire A., Porte H. etal. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients//Circulation. — 1996. — Vol. 94. — P. 1635.

O'Connell J.B. Diagnosis and medical treatment of inflammatory cardiomyopathy// Card. Vase. Dis. - 1998. - Vol. 3. - P. 132-143.

OhJ.K., HatleL., Seward J.B. etal. Diagnostic role of Doppler echocardiography in constrictive pericarditis //J. Amer. Coll. Cardiol. — 1994. — Vol. 23.— P. 154.

Okuno M., Nakagava M., Shimada M. Expressional patterns of cytokines in murine model of acute myocarditis // Lab. Invest. — 2000. — Vol. 80, 3. — p 433-440.

Oliveira J\S., Correa De Araujo R.R., Navarro M.A. et al. Cardiac thrombosis and thromboembolism in chronic Chagas heart disease //Amer. J. Cardiol. — 1983. — Vol. 52.-P. 147-152.

Olivetti G., Abbi R., Quaini F. et al. Apoptosis in the failing human heart // New Engl. J. Med. - 1997. - Vol. 336. - P. 1131-1141.

Olsen E.G.J. The value of endomyocardial biopsies in myocarditis and dilated cardiomyopathy//Europ. Heart J. - 1991. - Vol. 12, Suppl. D. - P. 10-12.

Olsen E.G.J., Rose M.L., Meany B. et al. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value // Europ. Heart J. - 1991. - Vol. 12 (Suppl.D). - P. 56-59.

Opie L.H. Angiotensin converting enzyme inhibition. 3th edition. New York: Wiley-Liss, 1999.-275 p.

Parmley WW Neuroendocrine changes in heart failure and their clinical relevance // Clin. Cardiol.- 1995. - \ . 18. - P. 440-445.

PaulusW.J., Shah A.M. NO and cardiac diastolic function //Cardiovasc. Res. — 1999.-Vol. 43.-P. 595-606.

Permanyer-Miralda G., Sagrista-Sauleda J., Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients // Amer. J. Cardiol. - 1985. - Vol. 56. - P. 623.

Peters N.S., Poole-Wilson Ph.A. Myocarditis-continuing clinical and pathologic confusion//Amer. Heart J. - 1991. - Vol. 121. - P. 942-947.

Pfeffer J.M., Pfeffer M.A. Angiotensin converting enzyme inhibition and ventricular remodelling in heart failure // Amer. J. Med. — 1988. — Vol. 84, Suppl. . - P. 37-44.

Pichardo J., Palace V, Farahmand F. et al. Myocardial oxidation stress changes during compensated right heart failure in rats // Mol. Cell. Biochem. — 1999. — Vol. 196.-P. 51-57.

Pinamonti ., Singara G., Salvi A. et al. Left ventricular involvement in right ventricular dysplasia//Amer. Heart J. - 1992. - Vol. 123. - P. 711-724.

Piovaccari G., Ferretti R.M., Prati F. et al. Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up //Int. J. Cardiol. ~ 1995. - Vol. 49. - P. 39.

Ponicke K.,Vogelsang M., Heinroth M. et al. Endothelin receptors in the failing and nonfailing human heart//Circulation. - 1998. -Vol.97. — P. 744-751.

Post S.R., Hammond H.K., Insel PA. -adrenergic receptors and receptor signaling in heart failure // Ann. Rev. Pharmacol. Toxicol. — 1999. — Vol. 39. — P 343-360.

PouleurH.etal. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction // Circulation. — 1993. — Vol. 88, 2.- P. 481-491.

Ram P., Chandra M.S. Unusual electrocardiographic abnormality in leptospirosis: Case reports//Angiology. - 1985. - Vol. 36. - P. 477-452.

Ramos H.C., EliasP.R., Barrucand L. etal. The protective effect of carnitine in human diphtheric myocarditis// Pediatr. Res. — 1984. — Vol. 18. — P. 815-817.

Rampazzo A., Nava A., Danieli G.A. et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24 // Hum. Mol. Genet. - 1994. - Vol. 3. - P. 959-962.

Rampazzo A., Nava A., Erne P. et al. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome Iq42—q43// Hum. Mol. Genet. - 1995. - Vol. 4. - P. 2151-2154.

Rauchhaus M., Doehner W, Francis D.P. et al. Plasma cytokine parameters and mortality in patients with chronic heart failure//Circulation. — 2000. — Vol. 102. — P. 3060-3067.

Recomendations for exercise training in chronic heart failure patients. Working Group Report// Europ.Heart J. - 2001. - Vol. 22. - P. 125-135.

Reddy PS., Curtiss E.L., Uretsky B.A. Spectrum of hemodynamic changes in cardiac tamponade//Am. J.Cardiol.— 1990. - Vol. 66. - P. 1487.

Regitz-Zagrosek V, Neuss M., Fleck E. Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects // Europ. Heart J. — 1995. — Vol. 16, Suppl. N . ~ P. 86-91.

Report of the WHO/ISFC task force on the definition and classification of cardiomyopaties// Circulation. - 1996. - Vol. 93. - P. 841-842.

Rerkrattanapipat P., Wongpraparut N. Cardiac manifestations of acqured immunodeficiency syndrome // Arch. Intern. Med. — 2000. — Vol.160, 5. — P. 602-608.

474

Reynen . Cardiac myxomas //New Engl. J. Med.— 1995.-Vol.333. - P. 1610. RobbMacLellanW. Death by design//Circ. Res. - 1997. — Vol. 81. — P. 137-

144.

Rodriguez-Artalejo E, Fuallar-Castillon P., Banegas Banegas J.R. et al. Trends in hospitalization and mortality for heart failure in Spain, 1988-1993 // Europ. Heart J. — 1997. - Vol. 18. - P. 1771-1779.

Rogg H. Angiotensin II receptor subtypes in human atria and evidence for alteration in patients with cardiac dysfunction//Europ. HeartJ. — 1996. —Vol. 17. — P. 1112-1120.

Roig E., Perez-Villa F, Morales M. etal. Clinical implications of increased plasma angiotensin II despite angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure // Europ. Heart J. - 2000. - Vol. 2. - P. 53-57.

RozyckiG.S.,FelicianoD.V, Schmidt J.A. etal. The role of surgeon-performed ultrasound in patients with possible cardiac wounds // Ann. Surg. — 1996. — Vol. 223.-P. 737.

Rubinstein E.> Carbon Staphylococcal endocarditisrecommendations for therapy// Clin. Microbiol. Infect. - 1998. - Vol. 4. - P. 27-33.

Rush J., Rajfer S. Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure// J. Hypert. - 1993.—Vol. 11 (Suppl. 3). - S. 69-71.

Saadia R., Levy R.D., Degiannis E. et al. Penetrating cardiac injuries: clinical classification and management strategy//Brit. J. Surg. — 1994. —Vol.81. — P. 1572.

Sagrista-Sauleda J., Permanyer-Miralda G., Candell-Riera J. et al. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis //Amer. J. Cardiol. - 1987. -Vol. 59. - P. 961.

Schick E.C. Jr. Nonpenetrating cardiac trauma // Cardiol. Clin. — 1995. — Vol. 13.-P. 241.

SchinkelA.,BaxJ. Echocardiographic follow-up of Chlamidia psittaci myocarditis// Chest. - 2000. - Vol. 117, 4. - P. 1203-1205.

Schonian U., Crombach M., Maisch D. Does CMV infection play a role in myocarditis? New aspects from in situ hybridization//Europ. HeartJ. — 1991. — Vol. 12 (Suppl. D). - P. 65-68.

Sekido M., Takano T, Takayama M. et al. Survey of infective endocarditis in the last 10 years: analysis of clinical, microbiological and therapeutic features // J. Cardiol. — 1999.-Vol. 33.-P. 209-215.

Seko Y, Shinkai Y, Kawasaki A. et al. Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B-3 // Circulation. — 1991.-Vol. 84.-P. 788-795.

SharpeN., Doughty R.N. Left ventricular remodelling and improved long-term outcomes in chronic heart failure//Europ. HeartJ. — 1998. —Vol. 19, Suppl. B. — P. 36-39.

Shen W.K., Edwards WD., Hammil S.C. etal. Right ventricular dysplasia: a need for precise pathological definition for interpretation of sudden death // J. Amer. Coll. Cardiol. - 1994. - Vol. 23. -P. 34A.

Singal P.K., Khaper N., Palace V. et al. The role of oxidative stress in the genesis of heart disease // Cardiovasc. Rres. - 1998. - Vol. 40. - P. 426-432.

Smith S.C, Ladenson J.H., Mason J.W. et al. Elevations of cardiac troponin I associated with myocarditis//Circulation. — 1997. — Vol. 95. — P. 163-168.

Spinale EG., Cocker M.L., Krombach S.R. et al. Matrix metalloproteinase inhibition during the development of chronic heart failureeffects on left ventricular dimensions and function // Circ. Res. - 1999. - Vol. 85. - P. 364-376.

Srivastava S.C, Puri D.S., Lumba S.T. An electrocardiographic study of myocarditis and diphtheria//J. Assoc. Phys. India. - 1966. - Vol. 14. - P. 365-368.

Stanek G., Klein J., Bittner R. et al. Isolation of Borrelia burgdorferi from the myocardium of a patient with long-standing cardiomyopathy// New Engl. J. Med. — 1990. - Vol. 322. - P. 249-252.

Steere A.C., Batsford W.P., Weinberg M. et al. Lyme carditis: Cardiac abnormalities of Lyme disease//Ann. Intern. Med. — 1980. — Vol.93. — P. 8-16.

Steere A.C., Taylor E., Wilson M. L. et al. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population //J. Infect. Dis. - 1986. - Vol. 154. - P. 295-300.

Stevens P.J., Underwood Ground K.E. Occurence and significance of myocarditis in trauma//Aerospace Med. - 1970. — Vol. 41. - P. 776-779.

Swynghedauw B. Molecular mechanisms of myocardial remodelling // Physiol. Rev. - 1999. - Vol. 79. - P. 215-262.

Symbas P.N. Traumatic heart disease//Curr. Probl. Cardiol. - 1991. - Vol. 16. - P. 537.

Takach T.J., Reul G.J., Ott D.A. et al. Primary cardiac tumors in infants and children: immediate and long-term operative results//Ann. Thorac. Surg. — 1996. — Vol. 62. - P. 559.

Tazelaar H.D., Locke T.J., McGregor C.G.A. Pathology of surgically excised primary cardiac tumors // Mayo Clin. Proc. — 1992. — Vol. 67. — P. 957.

Tesson F, Charron P., Peuchmaurd M.et al. Characterization of a unique genetic variant in the beta-1 adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy//J. Mol. Cell Cardiol. - 1999. - Vol. 31. - P. 1025-1032.

The SOLVE) investigator. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions // New Engl. J. Med. - 1992. - Vol. 327. - P. 685-691.

Thiene G., Nava A., Corrado D. et al. Right ventricular cardiomyopathy and sudden death in young people//New Engl. J. Med. - 1988. - Vol. 318. - P. 129-133.

Thisyakorn U., Wongvanich J., Rampens V. Failure corticosteroid therapy to prevent diphtheritic myocarditis or neuritis//Pediatr. Infect. Dis. — 1984. —Vol. 3. — P. 126-130.

Tonet J., Castro Miranda R., Iwa T et al. Frequency of supraventricular tachyarrhythmias in arrhythmogenic right ventricular dysplasia //Amer. J. Cardiol. — 1991.-Vol. 67.-P. 1153.

Tracova R., Niroumand M., Lorenzi-Filho G. et al. Overnight shift from obstructive to central apneas in patients with heart failure//Circulation. — 2001. — Vol. 103.-P. 238-243.

UrataH., NishimuraH.,Ganten D. Mechanisms of angiotensin II formation in humans // Europ. Heart J. - 1995. - Vol. 16, Suppl. N. - P. 79-85.

Ursell PC, Habib A., SharmaP.etal. Hepatitis virus and myocarditis// Hum. Pathol- 1984.-Vol. 15. - P. 481-485.

Vaitkus P.T., Kussmaul W.G. Constrictive pericarditis versus restrictive cardiomyopathy: a reappraisal and update of diagnostic criteria//Amer. Heart J. — 1991.-Vol. 122.-P. 1431.

VanderLinde M.R., Crijus H.J.G.M., Koning J. etal. Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports// Brit. HeartJ. - 1990. - Vol. 63. - P. 162-168.

Vanhouten N., Huber S.A. Genetics of Coxsackie-B3 myocarditis // Europ. HeartJ.- 1991.-Vol. 12 (Suppl. D.). - P. 108-112.

Waller B.F., Slack J.D., Prs CD. et al. "Flaming", "smoldering" and "burned out": the fireside saga of myocarditis // J. Amer. Coll. Cardiol. — 1991. —Vol. 18. — P. 1627-1630.

Walton B.I., Wallace S.M., Kharbanda R. et al. Factors associated with increased morbidity and mortality in the initial assessment of patients presenting with acute infective endocarditis //J. Amer. Coll. Cardiol. - 2000. - \ . 35, issue 2, Suppl.A. - P. 537.

Weinstein M.P., Towns M.L., Quartey S.M. et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremia and fungemia in adults // Clin. Infect. Dis. - 1997. - Vol. 24. - P. 584-602.

Weiss L.M., Movahed L.A., BillinghamM.E. etal. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction // Amer. J. Pathol. — 1991.- Vol. 138. - P. 497-503.

Wfeiss R.L., Brier J.A., O'Connor W. et al. The usefulness of transesophageal echocardiography in diagnosing cardiac contusions//Chest.— 1996.— Vol. 109.— P. 73.

WichterT, Borggrefe M, BreithardtG. Arrhythmogenic right ventricular disease// Z. Kardiol. - 1991. - Vol. 80. - P. 107-125.

Wichter ., Breithardt G., Block M. et al. Management of patients with arrhythmogenic right ventricular cardiomyopathy: results in 127 patients // New Trends Arrhythm. - 1993. - Vol. 9. - P. 749-755.

Wilson W.R. Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci and other streptococci//Clin. Infect. — 1998. —Vol.4. — P. 17-26.

Winearls C.G., Chan L., Coghlan J.D. et al. Acute failure due to leptospirosis: Clinical features and outcome in six cases // Amer. J. Med. — 1984. — Vol. 53. — R 487-489.

Wojnicz R., Nowalany-Kozielska E., Wilczewski P. et al. Effect of short-term immunosuppressive therapy on chronic inflammatory cardiomyopathy: two-year follow-up results//Europ. Heart J. — 2000. — Vol. 21,Abstr. Suppl. — P. 489.

Woodruff J.F. Viral myocarditis: a review//Amer. J. Pathol. — 1980. — Vol. 101. — P. 427-479.

Wynne J., Braunwald E. The cardiomyopathies and myocardities/ Heart diseaseWB.Saunders Company, 1988. — P. 1410-1469.

Zahger D., Miltgalter E. A broken heart // New Engl. J. Med. — 1996. — Vol. 334.-P. 319.

Zannad F, Alia F, Dousset B. etal. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Insights from the Randomised Aldactone Evaluation Study (RALES)//Circulation. - 2000. - Vol. 102. - P. 2700-2706.

ZhangH., LiY, Peng T eta!. New evidence of enterovirus persistence in myocytes in endomyocardial biopsy samples or explanted myocardium from patients with myocarditis or dilated cardiomyopathy: an immunohistochemical study// Europ. Heart J. - 2000. - Vol. 21, Abstr. Suppl. - P. 23.

Zhang H., Li Y Localization of enteroviral antigen in myocardium from pts with heart muscle disease//J. Histochem. Cytochem. - 2000. - Vol. 48, 5. - P. 579-84.

Ziskind A.A., Pearce A.C., Lemmon C.C. et al. Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases// J. Amer. Coll. Cardiol. — 1993.-Vol. 21.-P. 1.

3. ( )

-